Novelmed Therapeutics, Inc.

Doing business as Research Discovery Research

UEI
D5B7ANZ8LE45
CAGE
474Y5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Woman Owned Business
  • Woman Owned Small Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
novelmed.com
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Novelmed Therapeutics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Disease modifying treatment for hemolytic disorders - abstract our lead drug candidate is being developed as a disease… Grant · R44HL156774 National Heart Lung and Blood Institute $1,599,495
Treatment of complement-mediated myelitis - abstract we intend to develop our lead drug candidate as a potent,… Grant · R44AG072939 National Institute on Aging $900,000
Single therapy for wet AMD & geographic atrophy Grant · R44EY024809 National Institutes of Health $588,124
Preclinical and clinical evaluation of humanized NM9405 Grant · R44HL122028 National Heart Lung and Blood Institute $2,904,725
Complement inhibitors as dmoads Grant · R44AG041564 National Institutes of Health $681,386

Quick answers

What is Novelmed Therapeutics, Inc.'s UEI?

Novelmed Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is D5B7ANZ8LE45.

What is Novelmed Therapeutics, Inc.'s CAGE code?

Novelmed Therapeutics, Inc.'s CAGE code is 474Y5.

What is Novelmed Therapeutics, Inc.'s primary NAICS code?

Novelmed Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Novelmed Therapeutics, Inc. registered in SAM.gov?

Novelmed Therapeutics, Inc.'s SAM.gov registration expired on August 21, 2026.

What is Novelmed Therapeutics, Inc.'s most recent federal award?

Novelmed Therapeutics, Inc.'s most recent federal grant award is Disease modifying treatment for hemolytic disorders - abstract our lead drug candidate is being developed as a disease… (R44HL156774), from National Heart Lung and Blood Institute, on July 15, 2021.

On GovTribe

See Novelmed Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login